Platelet-to-lymphocyte ratio might predict the response to dupilumab treatment for patients with nasal polyposis

[1] Johansson L(2003)Prevalence of nasal polyps in adults: the Skövde population-based study Ann Otol Rhinol Laryngol 112 625-629

[2] Akerlund A(2018)Age-related prevalence of chronic rhinosinusitis and nasal polyps and their relationships with asthma onset Ann Allergy Asthma Immunol 120 389-394

[3] Holmberg K(2021)Prevalence and symptom burden of nasal polyps in a large Austrian population J Allergy Clin Immunol Pract 9 4117-4129.e2

[4] Won HK(2020)European position paper on rhinosinusitis and nasal polyps 2020 Rhinology 58 1-464

[5] Kim YC(2021)Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis Expert Opin Biol Ther 21 575-585

[6] Kang MG(2021)Cost utility analysis of dupilumab versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps Laryngoscope 131 E26-E33

[7] Campion NJ(2017)Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyposis Laryngoscope 127 29-37

[8] Kohler R(2017)Nasal polyps and biomarkers J Allergy Clin Immunol Pract 5 1589-1590

[9] Ristl R(2018)Zellzahl und Entzündungsparameter im peripheren Blut bei chronischer Rhinosinusitis [Peripheral blood cell count and inflammation-based markers in chronic rhinosinusitis] HNO 66 605-612

[10] Fokkens WJ(2016)A novel predictive marker for the recurrence of nasal polyposis following endoscopic sinus surgery Eur Arch Otorhinolaryngol 273 1439-1444

[1] Johansson L(2003)Prevalence of nasal polyps in adults: the Skövde population-based study Ann Otol Rhinol Laryngol 112 625-629

[2] Akerlund A(2018)Age-related prevalence of chronic rhinosinusitis and nasal polyps and their relationships with asthma onset Ann Allergy Asthma Immunol 120 389-394

[3] Holmberg K(2021)Prevalence and symptom burden of nasal polyps in a large Austrian population J Allergy Clin Immunol Pract 9 4117-4129.e2

[4] Won HK(2020)European position paper on rhinosinusitis and nasal polyps 2020 Rhinology 58 1-464

[5] Kim YC(2021)Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis Expert Opin Biol Ther 21 575-585

[6] Kang MG(2021)Cost utility analysis of dupilumab versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps Laryngoscope 131 E26-E33

[7] Campion NJ(2017)Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyposis Laryngoscope 127 29-37

[8] Kohler R(2017)Nasal polyps and biomarkers J Allergy Clin Immunol Pract 5 1589-1590

[9] Ristl R(2018)Zellzahl und Entzündungsparameter im peripheren Blut bei chronischer Rhinosinusitis [Peripheral blood cell count and inflammation-based markers in chronic rhinosinusitis] HNO 66 605-612

[10] Fokkens WJ(2016)A novel predictive marker for the recurrence of nasal polyposis following endoscopic sinus surgery Eur Arch Otorhinolaryngol 273 1439-1444